Pulse Pressure and Target Organ Damage by Berbari, Adel & Jurjus, Abdo
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
16 
Pulse Pressure and Target Organ Damage 
Adel Berbari and Abdo Jurjus  
American University of Beirut, 
Lebanon 
1. Introduction 
Hypertension remains the major risk for cardiovascular disease, stroke and end-stage 
nephropathy. Hypertension is traditionally defined in terms of elevated systolic and or 
diastolic blood pressure (BP). Recently, however, there has been increased recognition of the 
importance of high brachial pulse pressure (PP) as an important and independent predictor 
of increased cardiovascular morbidity and mortality, especially in senior subjects (Franklin 
et al., 2001). This paradigm shift is attributed to the aging of the population. The aging 
process is associated with an increased incidence of systolic hypertension, and in particular 
isolated systolic hypertension (ISH) (Franklin et al., 1999; Franklin et al. 2001; National High 
Blood Pressure Education Program Working Group, 1994). Both systolic and isolated 
systolic hypertension are characterized by wide (high) PP (Franklin et al. 2001 & National 
High Blood Pressure Education Program Working Group, 1994). 
Increased pulse pressure (PP) defined as the difference between inappropriately elevated 
systolic blood pressure (SBP) and reduced diastolic blood pressure (DBP) at any value of 
mean arterial pressure (MAP) is a surrogate measure of increased arterial stiffness of central 
elastic arteries (aorta and its major branches) (Figure 1) (Dart & Kingwell, 2001; Safar et al., 
2003). Arterial stiffness has emerged as an important independent predictor of adverse 
cardiorenal outcome in the general population (Figure 2) (Boutouyrie et al., 2002). Central 
PP is considered an accurate indicator of arterial stiffness (Boutouyrie et al., 2002). However, 
brachial PP is a widely accepted marker of arterial stiffness in the elderly and in some 
middle-aged individuals because central PP equalizes brachial PP during aging due to PP 
augmentation by early wave reflection (Dart & Kingwell, 2001). 
 
SBP= Systolic blood pressure, DBP= Diastolic blood pressure 
Fig. 1. Determinants of Central Pulse Pressure 
The relationship between PP and age is reported to be J-shaped, negative in subjects younger 
than 50 years and becoming positive after the age of 50 years. These findings suggest different 
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pathophysiologic implications in younger versus older subjects. In subjects younger than 50 
years of age, with preserved left ventricular dynamics, PP is related to a hyperdynamic 
cardiovascular state whereas, after the age of 60 years, arterial stiffening becomes a major 
determinant (Wilkinson et al., 2001). In fact, after the age of 60 years, the increase in PP results 
both from continuous elevation in SBP and a decrease in DBP (Franklin et al., 2001).   
 
LVH= Left ventricular hypertrophy, CAD= Coronary artery disease, CHF= Congestive heart failure, 
ESRD= Endstage renal disease 
Fig. 2. Relationship between increased arterial stiffness, increased pulse pressure and target 
organ disease 
Several observational and clinical studies have indicated that, in both normotensive and 
hypertensive middle-aged and older subjects, wide PP is a better predictor of cardiovascular 
events and target organ disease than increased SBP and MAP adjusted for age, sex and other 
cardiovascular risk factors (Franklin et al., 2001). Further, a level of PP that predicts 
cardiovascular events in hypertensive patients appears to be equal or greater than 60-
63mmHg (De Simone et al., 2005). 
An increased brachial PP is an independent predictor of cardiovascular mortality not only in 
hypertensive men but also in normotensive men aged 40-69 years (Benetos et al., 1998). 
Thus, normotensive men with PP > 55mmHg were shown to have a 40% increased 
cardiovascular risk compared to normotensive men with same age but PP< 45mmHg 
(Benetos et al., 1998). Further, the predictive value of PP was observed even in well 
controlled hypertensive subjects (Benetos et al., 1998). Finally, the predictive power of PP 
has been demonstrated in subjects with evidence of other target organ involvement such as 
left ventricular dysfunction, endstage renal failure and in those with diabetes mellitus 
(Schram et al., 2002). 
In contrast, in subjects younger than 50 years, brachial PP is not associated with a poor 
prognostic implication. In these subjects, the central arteries are more distensible and 
velocity of reflected pulse wave is low (Kotsis et al., 2011). As a result, SBP and PP increase 
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significantly by about 12-14mmHg from central to peripheral arteries. This is known as the 
amplification phenomenon (Franklin et al., 2001 & Karamanoglu et al., 1993). Central and 
peripheral MAP and DBP, however, are not significantly different. Consequently, the 
peripheral (brachial) SBP and PP overestimate central (aortic) values (Franklin et al., 2001 & 
Karamanoglu et al., 1993). After the age of 55-60 years, as a result of arterial aging, central 
SBP and PP may increase even more than peripheral pressures. As a result, central SBP and 
PP become equal to or higher than peripheral (brachial) SBP and PP (Figure 3) (Franklin et 
al., 2001; Karamanoglu et al., 1993; Kotsis et al., 2011). 
 
Fig. 3. Amplification phenomenon in younger and older adults 
2. Genesis of the pulse pressure 
The various BP components in the systemic circulation are the resultant of an interaction 
between left ventricular outflow (ejection) and properties of the large arterial system (aorta 
and its proximal major branches) (Benetos et al., 2010 & Van Bortel et al., 2001). 
Ejection of blood from the left ventricle (LV) generates flow and pressure waves (Safar et al., 
2003 & Wilkinson et al., 2001). The pressure wave generated by the LV travels down the 
arterial tree and is reflected back at any discontinuity of the arterial wall, namely at the 
multiple resistance arterioles and their bifurcation (Safar et al., 2003). The pressure 
waveform recorded at any site of the arterial tree is the sum of a forward traveling 
waveform, the incident pulse wave generated by left ventricular ejection and a back 
travelling wave, the reflected pulse wave (Safar et al., 2003 & Wilkinson et al., 2001).  
2.1 Youth and early adulthood 
In youth and early adulthood, the peak pressure recorded in the proximal aorta during LV 
ejection represents the SBP. Due to high distensibility of the system, the pressure wave form 
travels at low velocity (low pulse wave velocity- PWV) to the periphery and the reflected 
wave returns to the heart after closure of the aortic valve, so that it does not create an 
additional pressure load to the contracting LV (Safar et al., 2003). It does, however, increase 
the pressure during early diastole thereby enhancing DBP and improving coronary 
perfusion (Safar et al., 2003).  
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PP which represents pressure fluctuations resulting from episodic cardiac contraction is 
approximately 25mmHg in the aorta and is amplified to 40mmHg in the brachial and radial 
arteries. 
2.2 Aging 
In humans, the aging process is associated with structural and functional changes in the 
aorta and proximal elastic arteries. These vessels dilate and stiffen.  
With increased arterial stiffness, the pulse wave travels faster, and reflected pulse wave 
merges earlier with the incident wave, augmenting aortic systolic blood pressure, rather 
than diastolic blood pressure (Safar et al., 2003 & Wilkinson et al., 2001). As a result, left 
ventricular load is increased and coronary perfusion is compromised (Safar et al., 2003 & 
Wilkinson et al., 2001). 
3. Amplification phenomenon 
BP amplification is defined as the elevation of PP from the central aorta towards the 
periphery and is mainly attributed to an increase in SBP (Benetos et al., 2011; McEniery et 
al., 2005). Pressure wave amplification can be explained by the reflection phenomenon of 
the oscillating BP wave (Benetos et al., 2011; McEniery et al., 2005). In the presence of 
compliant (i.e. low stiffness) central elastic arterial system as in young adults, PWV is low, 
the reflected pulse wave will attain the peripheral arteries (i.e. radial arteries) during 
systole due to their proximity to the reflecting sites, and the central arteries during the 
diastolic period (Benetos et al., 2011). This mechanism explains PP phenomenon namely 
why the peripheral (brachial, radial) is higher than the central (aortic) PP. The ratio of 
brachial / central PP varies from 70% in subjects younger than 20 years to 20% in those 
older than 80 years (McEniery et al., 2005). When expressed in absolute change in mmHg, 
the difference between brachial and central PP varies from 20 to 7 mmHg (Benetos et al., 
2011; McEniery et al., 2005). Loss of PP amplification, associated with an increase in 
central PP and PWV have been shown to be significant predictors of all cause and 
cardiovascular mortality (Benetos et al., 2010).  
3.1 Determinants of PP amplification 
Several factors have been postulated to alter PP amplification including aging, gender, and 
traditional risk factors (McEniery et al., 2005). 
In youth and early adulthood, PP increases significantly from central (aorta / proximal 
elastic arteries) to peripheral (brachial) arteries, leading to PP amplification. This 
phenomenon is attributed to higher SBP and slightly lower DBP in peripheral (brachial, 
radial) arteries. In contrast, MAP gradient between central and peripheral arteries is only 1-
2mmHg. 
In middle-aged and elderly subjects, the increasing stiffness of central elastic arterial system 
is associated with elevation of central SBP, reduction in DBP, widening of central PP and 
loss of PP amplification. 
Females have a lower PP amplification than males of similar age which is attributed to: 
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i. i) shorter arterial tree;  
ii. ii) additional gender related factors.  
Subjects with hypertension, diabetes, dyslipidemia or established CV disease tend to have a 
low PP amplification independent of age, height or gender.  
Age and gender remain the major determinants of PP amplification. 
4. Kidney damage and pulse pressure 
It is well established that hypertension and chronic kidney disease (CKD) are closely linked. 
Hypertension is the second most common primary diagnosis in patients with incident or 
prevalent endstage renal disease (ESRD). Further, most forms of CKD are etiologically 
related to hypertension (Udani et al., 2011). In addition, coexistent or superimposed 
hypertension is the major risk for progression of CKD (Hsu et al., 2005; Perry et al., 1995; 
Udani et al., 2011). The rates of CKD and ESRD in the USA attributed to hypertension have 
been steadily increasing partly attributed to the aging process (Udani et al., 2011).  
Epidemiologic data and several clinical studies have documented a graded relationship 
between degree of BP elevation and renal functional impairment. Malignant hypertension, 
characterized by marked BP elevations (SBP/DBP ≥  220/120mmHg) leads, if untreated, to 
severe renal damage and irreversible renal failure which is attributed to occlusive intra-
renal arterial and arteriolar lesions (Bidani and Griffin, 2004). Conversely, data from several 
cohort studies provide strong support for nonmalignant hypertension as a causal risk for 
development of CKD and endstage renal failure (ESRD). In 12000 hypertensive patients 
from multiple Veterans Administration Centers followed up for 15 years, Perry et al. 
reported that uncontrolled hypertension was associated with a risk for development of 
CKD/ESRD(Perry et al., 1995). Specifically, the risk ratio for CKD was 2.8 for a pre-
treatment  SBP= 166-180mmHg, and 7.6 for a pre-treatment SBP>180mmHg (Perry et al., 
1995).   
Even modest BP elevation in the non-hypertensive range appears to confer increased risk of 
CKD. Compared to BP< 120/80mmHg, the adjusted risk ratio for developing ESRD was 1.62 
for BP=120-129/80-84 mmHg and 1.98 for BP=130-139/84-89 mmHg in a cohort of 316675 
adult members of the Kaiser Permanente of Northern California (Hsu et al., 2005). 
4.1 Hypertensive nephropathy 
4.1.1 Histopathologic patterns 
Hypertension-induced kidney damage can be classified into two clinical and histopathologic 
patterns: 1) vascular, 2) glomerular. 
The vascular pattern, often referred as nephrosclerosis can be further subdivided into two 
forms – namely benign and malignant nephrosclerosis (Bidani and Griffin, 2004). Benign 
nephrosclerosis, the most frequent form which occurs in the majority of patients with 
essential hypertension, is characterized by hyaline arteriosclerosis which is slowly 
progressive but does not compromise the vascular lumen (Bidani and Griffin, 2004). 
Accordingly, significant loss of nephrons and compromise of renal function are infrequent 
(Bidani and Griffin, 2004). In contrast, malignant hypertension is characterized by marked 
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BP elevation (SBP/DBP ≥ 220/120 mmHg) and occlusive arterial and arteriolar 
preglomerular lesions with prominent fibrinoid necrosis leading to ischemic glomerular 
injury (Bidani and Griffin, 2004). Rapid deterioration of renal function and irreversible renal 
failure can develop in the absence of adequate BP reduction (Bidani and Griffin, 2004). 
However, with the availability of effective modern antihypertensive therapy, malignant 
hypertension has become an uncommon cause of ESRD. 
The glomerular pattern, characterized by an accelerated segmental or global 
glomerulosclerosis, is an increasingly recognized lesion of hypertension-induced kidney 
damage (Bidani and Griffin, 2002 & Bidani et al., 2009). It is often superimposed on the 
underlying primary nephropathy and occurs even with mild to moderate BP elevations. 
Further, these histopathologic renal changes are independent of presence of nephrosclerosis 
(Bidani and Griffin, 2002 & Bidani et al., 2009). In fact, vascular lesions are not prominent. 
4.1.2 Mechanisms of hypertension-induced nephropathy (CKD) 
The mechanisms of hypertension-induced renal injury and appearance of hypertensive 
nephropathy have not been completely elucidated.  A growing body of evidence suggests a 
link between aortic stiffness and renal function (Mimran, 2006). Aortic stiffness causes 
increased SBP and wide (increased) PP, both factors associated with increased rates of 
decline in renal function and progression to renal impairment (Mimran, 2006). 
4.2 Renal autoregulation 
Disturbances in the mechanisms of renal autoregulation appear to play important roles in 
the appearance and progression of hypertensive nephropathy (Loutzenhiser et al., 2006).  
One of most striking features of the renal circulation is the phenomenon of autoregulation 
by which the kidney maintains constant renal blood flow (RBF) and glomerular filtration 
rate (GFR) in the face of wide fluctuations of systemic BP (Loutzenhiser et al, 2002). This 
dual regulation of both RBF and GFR is achieved by proportionate changes in the tone of 
the preglomerular and postglomerular resistances (Loutzenhiser et al, 2002). This process 
is initiated by combination and integration of two mechanisms, the faster renal myogenic 
response and the slower tubuloglomerular feedback (TGF) system (Loutzenhiser et al, 
2002). TGF involves a flow-dependent signal that is sensed at the macula densa and alters 
the tone of the adjacent preglomerular and postglomerular resistances (Loutzenhiser et al, 
2002). The renal myogenic response involves a direct vasoconstriction of the afferent 
arteriole when this vessel is exposed to an increase in transmural pressure (Loutzenhiser 
et al, 2002, 2006). 
By using the hydronephrotic rat kidney preparation, Loutzenhiser et al reported that the 
myogenic response is influenced only by the SBP, even when MAP is kept constant 
(Loutzenhiser et al, 2002, 2006).  
Normally, increases in systemic BP, whether sustained or intermittent are prevented from 
fully reaching the renal microcirculation by proportionate vasoconstriction of the 
preglomerular afferent arterioles (Loutzenhiser et al, 2002, 2006). Systolic BP and PP appear 
to be the major determinants of the tone of the afferent arterioles, independent of MAP and 
DBP (Loutzenhiser et al, 2002, 2006). In fact, recent clinical studies indicate that hypertensive 
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renal injury correlates most strongly with SBP and PP (Ford et al., 2010; Mimran, 2006; Safar, 
2004; Verhave et al., 2005). 
In contrast to the microcirculation of other organs, the renal microcirculation presents two 
special features. First, glomerular MAP and pulsatile pressures are high, representing about 
60% of the aortic pressures (Mitchell, 2004). Second, because the resistance is higher in the 
efferent arteriole than in the afferent arteriole, the pressure drop across the afferent arteriole 
is low (Mitchell, 2004). These hemodynamic characteristics allow the maintenance of 
glomerular filtration but expose the glomerular microcirculation to high pressure injury and 
biotrauma (Mitchell, 2010). Under normal conditions, the renal myogenic response prevents 
transmission of the elevated MAP and pulsatile pressure from reaching the glomerular 
capillaries (Loutzenhiser et al, 2002). 
Renal autoregulation mediates hypertension-induced nephropathy (CKD) by 2 mechanisms: 
i) intact renal autoregulation associated with elevated systemic BP levels within or beyond 
the autoregulatory threshold; ii) impaired renal autoregulatory process. 
4.2.1 Intact renal autoregulation 
4.2.1.1 Elevated systemic BP levels within the autoregulatory threshold 
In mild to moderate uncomplicated essential hypertension, the renal autoregulatory 
mechanisms are intact and BP levels remain within the autoregulatory threshold (Bidani & 
Griffin, 2002, 2004). The elevated systemic BP enhances the myogenic tone of the afferent 
arteriole, preserving the relative constancy of the glomerular capillary hydrostatic pressures 
and insulating the renal microcirculation from biotrauma (Bidani & Griffin, 2002, 2004). 
Renal functional impairment is minimal and development of CKD and ESRD is infrequent 
(Bidani & Griffin, 2002, 2004). However, prolonged exposure of the renal circulation to 
elevated systemic BP levels may initiate the pattern of benign nephrosclerosis in the afferent 
arterioles which is characterized by vascular lesions of nonspecific hyaline arteriosclerosis 
(Bidani & Griffin, 2002, 2004).  
4.2.1.2 Elevated systemic BP beyond the autoregulatory threshold 
In contrast, in malignant hypertension, although the autoregulatory process is still 
preserved, the markedly elevated MAP levels, which exceed the upper threshold of the 
process, may cause severe renal vascular and glomerular disruptive lesions, resulting in 
severe renal functional impairment (Bidani & Griffin, 2002, 2004). However, with the advent 
of renal vascular disease, renal autoregulatory responses may become secondarily impaired 
leading to amplification of the renal damage.  
A sudden severe BP elevation is much more likely to exceed the autoregulatory threshold 
than a progressive rise in BP to the same levels. This is due to the protection afforded by the 
rightward shift of the upper and lower limits of autoregulation, a characteristic feature in 
chronic hypertension (Bidani & Griffin, 2004).  
4.2.2 Impaired renal autoregulation 
Impaired renal autoregulation is frequently reported in states such as diabetes and CKD 
(Bidani & Griffin, 2004). This hemodynamic alteration tends to be manifested as dilatation of 
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the afferent arteriole, glomerular hypertrophy, hyperfiltration injury and subsequent 
extracellular matrix production and glomerulosclerosis with irreversible reduction in GFR 
(Bidani & Griffin, 2004). In addition, increased aortic stiffness may contribute directly to 
renal injury by favoring increased transmission of PP to the renal microcirculation (Bidani & 
Griffin, 2004). Unlike benign and malignant nephrosclerosis, the histological lesions are 
glomerular, being characterized by glomerulosclerosis (Bidani & Griffin, 2004). 
4.3 Clinical studies – Relation between SBP/PP and renal vascular nephropathy 
Several longitudinal and cross-sectional studies indicate a relation between an increase in 
arterial stiffness and its corollaries, increased SBP/PP, and injury to the renal 
microcirculation. 
4.3.1 Essential hypertension 
4.3.1.1 Systolic blood pressure (SBP) 
In the Systolic Hypertension in the Elderly Program (SHEP) conducted in subjects older 
than 65 years with ISH, SBP emerged as the best predictor of an increase in serum creatinine 
within a 5-year period (Young et al., 2002). Similarly in a cohort of 722 subjects with treated 
essential hypertension, the decrease in GFR, within a 7-year observation period, was 
preferentially associated with baseline SBP (Vupputuri et al., 2003). 
4.3.1.2 Pulse pressure (PP) 
Other clinical investigations revealed an association between PP and decline in renal 
function in older subjects. Fesler et al reported that in 132 never treated essential 
hypertension patients at baseline followed on treatment for 6.5 years, the yearly change in 
GFR was strongly and inversely correlated with PP independent of baseline GFR, age, MAP, 
body mass index, and microalbuminuria (Fesler et al., 2007). Gosse et al reported similar 
findings (Gosse et al., 2009). Measured either on clinic examination or by ambulatory BP 
monitoring in 375 patients with uncomplicated essential hypertension without proteinuria 
over a mean follow-up period of 14 years, initial baseline PP was an independent 
determinant of decline in renal function, pointing to the role of BP pulsatility as a 
glomerular biotrauma (Gosse et al., 2009).  
4.3.2 Chronic Kidney Disease (CKD) 
Aortic stiffening has been shown to predict loss of renal function also in CKD. Ford et al 
evaluated the relation between arterial stiffness and changes in renal function in 120 patients 
with CKD stage 3 and 4 enrolled in the prospective ACADEMIC (Arterial Compliance and 
Oxidant Stress as Predictors of Loss of Renal Function, Morbidity and Mortality in Chronic 
Kidney Disease (CKD) study) cohort (Ford et al., 2010). These investigators noted that, 
compared to those with lower PWV (12.3 m/sec), patients with higher PWV   (13.9 m/s) 
experienced a greater progression of CKD, as determined by a greater decrease in the 
reciprocal of serum creatinine and greater than 25% decline in estimated glomerular 
filtration rate during 1 year follow-up (Ford et al., 2010). 
Conversely, decreasing renal function may promote risk of accelerated rate of aortic 
stiffening. In 1290 untreated normotensive and hypertensive subjects with a serum 
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creatinine < 130 µmol/L (< 1.47 mg/dl), Mourad et al reported an inverse association 
between aortic PWV and creatinine clearance calculated by the Cockcroft-Gault formula 
(Mourad et al., 2001). However the aortic PWV was significantly enhanced only in subjects 
exhibiting a reduced creatinine clearance in the lower tertile of normal values particularly in 
younger than 55 years of age. Baseline serum creatinine was the only predictor of the 
changes in arterial function (Mourad et al., 2001). 
Similar associations between reduction in GFR and an acceleration of PWV were reported in 
the CRIC study in which unadjusted analysis indicated that each 10ml/min/1.73m2 
decrease in estimated GFR was associated cross-sectionally with a 0.5 m/s increase in aortic 
PWV (Townsend et al., 2010). 
In patients with ESRD (stage V) ,  increased aortic stiffening, as measured by PWV may be a 
contributor to further deterioration in renal structure and function. Several uremia related 
factors have been postulated to account for the disease of the large arterial system (Udani et 
al., 2011). 
4.4 Aging 
The aging process is often associated with reduced renal function (Mimran, 2006). In the 
Multiple Risk Factor Intervention Trial (MRFIT), a high risk of ESRD was reported in 
patients with isolated systolic hypertension (ISH) (Klag et al., 1996). In a cohort of 212 
patients with ISH, an inverse relationship between PP and GFR and effective renal plasma 
flow (ERPF) was documented in subjects 60 years of age and older independent of age, MAP 
and known cardiovascular factors (Verhave et al., 2005). This inverse relationship, however, 
was observed in elderly subjects exhibiting the highest tertile of PP (Verhave et al., 2005).  
4.5 Microalbuminuria and pulse pressure 
Increased urinary albumin excretion (UAE) is a well recognized risk for cardiovascular 
morbidity and mortality and a predictor of renal involvement (Sarnak et al., 2003).   
The pathophysiologic mechanisms causing increased UAE have not been fully elucidated. 
However a link between BP and UAE is well recognized. Although earlier studies 
emphasized an association between DBP/MAP and UAE, more recent studies report 
stronger relations between SBP/PP and UAE (Farasat et al., 2010). In a cross-sectional study 
that included 211 untreated controls, patients with essential hypertension or clinically stable 
cardiovascular disease, Pedrinelli et al found that PP was the best predictor of UAE, defined 
as UAE≥15 µg/min (Pedrinelli et al., 2000). Similarly in a longitudinal study of 450 
normotensive and untreated hypertensive subjects drawn from the Baltimore Study of 
Aging, only longitudinal levels of SBP and PP, pulsatile BP components, were independent 
predictors of UAE in men (Pedrinelli et al., 2000). 
4.6 Renal transplantation and pulse pressure 
Increased PP, a sign of arterial stiffness, is frequently recorded in renal transplant recipients 
(Fernandez-Fresnedo et al., 2005).  
Several studies have demonstrated a relationship between PP and renal allograft function 
and survival. In a cohort of 493 renal transplant recipients with a median follow-up of 6.3 
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years, increased PP, recorded 3 months post-transplant emerged as an early and strong 
marker of poor allograft outcome (Bahous et al., 2006; Vetromile et al., 2009).Further, recent 
data suggest that immunosuppressive regimens which include Calcineurin inhibitors may 
also mediate both an increased risk of arterial stiffness and allograft dysfunction (Seckinger 
et al., 2008). Adequate BP control and immunosuppressive therapy free of Calcineurin 
inhibitors have been recommended to improve allograft outcome and prevent 
nephrotoxicity (Seckinger et al., 2008 & Vetromile et al., 2009).   
5. Cardiovascular disease and pulse pressure 
Epidemiologic surveys and clinical observations have established a strong association 
between indices of arterial stiffness (peripheral PP, central PP, aortic PWV, pressure wave 
amplification) and cardiovascular events in hypertensive and older subjects.  
5.1 Structural and functional changes in the cardiovascular system 
Arterial stiffness is associated with structural and functional changes in the central elastic 
arteries (aorta and proximal elastic branches). These vessels dilate and stiffen (Lakatta, 
2003). The primary cause of the stiffening is marked disorganization of the normal elastic 
pattern, increased deposition of less extensible collagen fibers, fibrosis, inflammation, 
medial smooth muscle necrosis, calcification and diffusion of macromolecules into the 
arterial wall (Lakatta, 2003). The repetitive cycles of distension of the arterial wall which 
occur with each heart beat lead to fatigue, fraying and fracture of the elastic fibers and 
subsequent extensive impairment of the medical elastin fiber network (Lakatta, 2003).  
With increasing stiffness of the central elastic arteries, pulse wave velocity is faster, leading 
to summation of reflected and incident pulse waves in systole, enhancing central SBP, 
reducing DBP and widening central PP (Benetos et al., 2010). The elevation in central SBP 
increases myocardial oxygen demand, enhances left ventricular load, generates a heightened 
LV systolic pressure to sustain a constant blood flow and impairs ventricular ejection. 
Moreover, the contemporary reduction in DBP, the latter being a determinant of coronary 
blood supply, compromises coronary perfusion, predisposes to subendocardial ischemia, 
myocardial infarction and arrhythmias (Mosley et al., 2007). Both an elevated SBP and wide 
PP promote hypertrophy of the left ventricle, with impaired left ventricular relaxation and 
diastolic heart failure (Mosley et al., 2007). Finally, PP, an index of oscillatory hemodynamic 
forces, is a significant modulator of formation and rupture of atherosclerotic plaques 
(Mosley et al., 2007).  
Endothelial dysfunction and reduced bioavailability of nitric oxide, frequently associated 
with arterial stiffness, impair and limit the vasoactive and antiatherosclerotic properties of 
the vascular endothelium (Mosley et al., 2007). 
A cross-talk has been recently documented between the central elastic arterial system and 
microcirculation of target organ damage (O’Rourke and Safar, 2005). Arterial stiffness and 
PP have a negative impact on the microcirculation of the kidney and brain, predisposing 
to renal impairment and deterioration in neurocognitive function (O’Rourke and Safar, 
2005). 
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5.2 Clinical studies 
Recent prospective and retrospective epidemiologic and clinical studies have demonstrated 
that an elevated PP is independently related, in both middle aged and older subjects, to an 
increased risk of cardiovascular events. In two independent French untreated male cohorts, 
the IPC (Investigations Preventives et Cliniques) composed of 15561 men aged 20 to 82 years 
who had 2 visits spaced 4 to 10 years apart, and the Paris Prospective Study including 6246 
men aged 42 to 53 years examined over a period of 4 years, Benetos et al reported that an 
increase in SBP  combined with a reduction in DBP, a hemodynamic pattern characteristic of 
wide PP, was associated with a highest risk of cardiovascular mortality, independent of age, 
initial BP levels and other risk factors (Benetos et al., 2000). In a different study, these same 
investigators noted that in untreated subjects, a spontaneous evolution towards a pattern of 
combined increase in SBP and reduced DBP over an extended period was associated with a 
2 fold increase in cardiovascular mortality compared to those without changes in SBP and 
DBP (Benetos et al., 2000).  
The relationship between pulsatile BP components and risk of cardiovascular events was 
also explored in 1109 patients with coronary artery disease. Intra-aortic BP indices were 
recorded during coronary angiography in these patients (Jankowski et al., 2008). After a 4.5 
year follow-up, the ascertained primary endpoints (cardiovascular death, myocardial 
infarction, stroke, cardiac arrest, cardiac transplantation or myocardial revascularization) 
occurred in 22% of the patients (Jankowski et al., 2008). Central pulsatility (defined as 
PP/MAP) and central PP emerged as the primary endpoints with ratios of 1.3 and 1.25 
respectively suggesting that central pulsatile BP indices were more important determinants 
of risk of cardiovascular events than steady BP components in patients with coronary artery 
disease (Chirinos et al. & Jankowski et al., 2008).  
Premature stiffening of the arterial tree is frequently reported in insulin resistance and diabetes 
(Kengne et al., 2009 & Stehouwer et al., 2008). In the recent ADVANCE (Action in Diabetes and 
Vascular Disease: Preterax and Diamicron- Modified Release Controlled Evaluation Study) a 
clinical trial which enrolled 1140 subjects with type 2 diabetes, older than 55 years and one 
additional cardiovascular risk factor, the hazard ratio for cardiovascular events was 1.17 for 
SBP, 1.20 for PP, 1.12 for MAP and 1.04 for DBP. The investigators concluded that SBP and PP 
were the two best and DBP the least effective determinants of risk of major cardiovascular 
outcomes in relatively older diabetic patients (Kengne et al., 2009). 
PP has been shown to be a predictor of heart failure especially in the elderly. In a sample of 
2512 subjects aged ≥ 65 years, participants in the Established Population for Epidemiologic 
Study for the Elderly Program free of cardiovascular heart disease (CHD) and congestive 
heart failure (CHF) at baseline, a 10mmHg increment in PP was associated with an increased 
risk of CHD, CHF and overall mortality of 12%, 14% and 6% respectively both in 
normotensive subjects and in those with ISH (Vaccarino et al., 2000). 
6. Cerebrovascular disease, stroke, neurocognitive dysfunction and pulse 
pressure 
Several studies, in both population and patient-based cohorts have demonstrated a strong 
association between increased brachial PP and excess risk of stroke and neurocognitive 
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dysfunction in both elderly and middle aged subjects (Hanon et al, 2005; Paultre & Mosca, 
2005). 
6.1 Mechanisms of cerebrovascular events 
An increased arterial stiffness can enhance the risk of stroke through several mechanisms. 
An elevation in central PP enhances arterial remodeling both at the site of the extracranial 
and intracranial arteries, increasing carotid wall thickness, and predisposing to carotid 
stenosis, formation of atherosclerotic plaques and the likelihood of their rupture (Laurent et 
al., 2009). Central PP has been associated with increased prevalence and severity of cerebral 
white matter lesions (Kim et al., 2011 & Scuteri et al., 2011). A second mechanism relates to 
the specific features of the cerebral circulation. The torrential cerebral blood flow and low 
cerebrovascular resistance expose the cerebral microcirculation to high pressure fluctuations 
in the carotid and vertebral arteries which tend to increase three-to fourfold with age 
(O’Rourke & Safar, 2005). Finally, coronary heart disease and heart failure, often associated 
with arterial stiffness and high central PP, are also risk factors for stroke (Selvetella et al., 
2003). 
6.2 Clinical studies  
Several epidemiologic surveys and clinical studies have documented that, in the elderly, 
high brachial PP was more predictive for stroke incidence and mortality than elevated SBP 
(>140mmHg). In the Boston Veterans Administration Study, PP was a stronger predictor for 
fatal cardiovascular outcome than were SBP and DBP among elderly subjects aged 60-85 
years (Waldstein et al., 2008). Similar observations were reported in a prospective study of 
5092 Chinese subjects. In this study, the incidence of total stroke, either ischemic or 
hemorrhagic, was related to PP (Zhang et al., 2004). In contrast, several other prospective 
studies identified SBP as a stronger predictor for incidence and mortality of stroke than PP 
(Miura et al., 2009). 
Further, there is growing evidence that response of PP to antihypertensive therapy may also 
be relevant to outcome. In a post-hoc analysis of Systolic Hypertension in the Elderly 
Program (SHEP) trial data, an increase in PP (>10mmHg) on active drug treatment was 
associated with an increased risk of stroke (Vaccarino et al., 2001).. Another analysis of the 
same study revealed the enhanced risk of stroke resulted from excessive reduction in DBP 
with a threshold at about 60mmHg (Somes et al., 1999).  
Elderly patients often have multiple comorbid conditions. These subjects are at increased 
postoperative complications when undergoing major surgical procedures. In a recent 
prospective study, a high brachial PP (>72mmHg) was reported to be associated with an 
increased risk of stroke during the postoperative period (Benjo et al., 2007).  
In contrast to the well established relationship between brachial PP and risk of stroke in the 
elderly, data in middle aged subjects are controversial. A meta-analysis of prospective 
cohort studies reported that PP was not an independent risk factor for stroke. However, in a 
recent large cohort Japanese study which included 33372 participants free of cardiovascular 
disease at baseline and followed for 12 years, the JPHC study, PP was an independent stroke 
predictor among middle aged subjects with SBP<140mmHg, but not among those with 
higher SBP (Okada et al., 2011). Among persons of SBP<140mmHg, a 10mmHg higher PP at 
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baseline was associated with 8.31mmHg higher SBP and 1.69mmHg lower DBP at baseline 
(Okada et al., 2011). These data suggest that, in middle aged subjects with SBP<140mmHg, it 
is the low DBP rather than the non hypertensive SBP which impacts the excess stroke risk 
(Okada et al., 2011). 
Increased brachial PP is also a risk predictor for neurocognitive dysfunction in healthy 
elderly and middle aged normotensive and hypertensive individuals (Robbins et al., 2005). 
Impairment of cognitive function and memory loss are frequent in the aging population, 
especially among the elderly subjects (Henskens et al., 2008). Alzheimer’s disease and 
vascular dementia are the most devastating manifestations of these neurocognitive 
disorders. Several longitudinal studies have emphasized an association between these 
dementias with increased PWV and a wide brachial PP, both indices of increased arterial 
stiffness (Qiu et al., 2003). In a community based cohort of 1270 elderly subjects (mean age ≥ 
75 years) free of dementia at baseline, higher brachial PP (> 84 versus 70-84mmHg) was 
associated with increased risks of both Alzheimer’s disease and vascular dementia (adjusted 
relative risks of 1.9 and 1.7 respectively) (Qiu et al., 2003). The association was particularly 
pronounced among women.  
7. Therapeutic approaches  
It is well established that reduction in BP and or improvement in arterial stiffness are 
associated with a reduction in risk of cardiovascular events (Dart & Kingwell, 2001). 
However it is often difficult to separate the effects of antihypertensive therapy on BP 
reduction alone from their direct effects on vascular wall properties. In fact, interventions 
that reduce BP and improve cardiovascular outcome are often associated with improvement 
in indices of arterial stiffness (PWV, PP) (Laurent et al., 2006; Laurent & Boutouyrie, 2007; 
Van Bortel et al., 2001).  
Therapeutic mechanisms include both lifestyle issues and pharmacologic treatment.  
7.1 Lifestyle measures  
A large number of lifestyle measures have been postulated to reduce both BP and arterial 
stiffening. These include body weight reduction, exercise, lowering salt intake, smoking 
cessation and moderation of alcohol consumption.  
7.1.1 Weight reduction 
Intentional weight reduction in obese hypertensive subjects is associated with significant fall 
in BP.  Several clinical studies have shown that obese subjects whether normotensive or 
hypertensive exhibit increased arterial stiffness with its associated hemodynamic indices 
(increased PWV and PP) (Orr et al., 2008). In these subjects, weight loss with a hypocaloric 
diet improved arterial stiffness and reduced PWV and PP (Dengo et al., 2010). In some 
studies, an improvement in endothelial function was also reported (Miyaki et al., 2009).  
7.1.2 Dietary supplement 
Several dietary supplements appear to improve functional characteristics of the elastic 
arterial system. Supplementation with n-3 polyunsaturated fatty acids reduces arterial 
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stiffness in dyslipidemic subjects, probably by decreasing serum triglycerides (Nestel et al., 
2002). A high dietary intake of isoflavones, the non-steroidal plant derived compounds rich 
in soy beans, and administration of red clover isoflavones reduce PWV (Van Der Schouw et 
al., 2002). These effects have been attributed to the affinity of isoflavones to human estrogen 
receptors. 
Recent reports have demonstrated that cocoa use ameliorated endothelial function, as 
evidenced by improved endothelial flow mediated vasorelaxation (Ferri, 2006). Changes 
were more striking in older subjects. The amelioration in endothelial function has been 
attributed to the flavanols, a subclass of flavanoids, present in large quantities in cocoa 
beans (Ferri, 2006). Controlled experiments conducted with beverages rich in flavanoids 
(wine, fruit, vegetable, tea, purple grape juice) have documented similar endothelial benefits 
(Ferri, 2006).  
The cocoa related improved endothelial functions have been linked to increased 
bioavailability of nitric oxide (Ferri, 2006). In clinical trials, cocoa supplementation has been 
associated with BP reduction in subjects with grade I hypertension, with ISH and in younger 
soccer players (Ferri, 2006; Taubert et al., 2003).  
7.1.3 Salt intake 
Salt is the most potent modulator of arterial stiffness (Zieman et al., 2005). High salt intake 
enhances the age-related changes in the vascular system (Zieman et al., 2005). High salt 
intake increases MAP and triggers structural and functional pressure-independent changes 
in the vascular wall. In experimental animals, exposure to high salt diet has been associated 
with alterations in the composition of the vascular wall that precede BP elevations by 
several weeks (Limas et al., 1980). In the human, short- and long-term salt restriction causes 
an improvement in arterial distensibility independent from the effect on BP levels (Aviolo et 
al., 1986). In a group of elderly subjects (mean age 64 ± 2 years) with isolated systolic 
hypertension, dietary salt restriction for 4 weeks was associated with fall in both supine 
resting SBP (≈ 6mmHg), ambulatory SBP (≈ 3mmHg) and enhanced carotid artery 
compliance by 46% (Gates et al., 2004). 
7.1.4 Alcohol consumption  
An association between alcohol consumption and increased arterial stiffness has been 
reported in several studies (Sierksma et al., 2004; Zieman et al., 2005). Conversely, 
moderation of alcohol intake appears to reduce significantly PWV in both genders, 
independently of changes in BP levels (Sierksma et al., 2004; Zieman et al., 2005).      
7.1.5 Physical exercise  
The age related increase in arterial stiffness can be partly reversed by a program of physical 
training. In middle aged sedentary men, 3 months of aerobic training (walking or jogging 40 
minutes daily at 70-75% of maximum heart rate) enhanced arterial compliance to levels 
observed in similarly aged endurance trained subjects (Tanaka et al., 2000). However, 
moderate exercise does not appear to improve arterial stiffening in elderly subjects with 
isolated systolic hypertension (Miyachi et al., 2003; Tanaka et al., 2000; Zieman et al., 2005).    
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In contrast, resistance training (weight lifting) has been reported to increase arterial stiffness 
and is associated with more severe increase in left ventricular mass compared to sedentary 
controls (Bertovic et al., 1999).  
7.2 Pharmacologic approach 
Although antihypertensive therapy has targeted brachial (peripheral) BP parameters, recent 
studies suggest that control of central hemodynamic indices (central SBP, PP, PWV) afford 
better cardiorenal protection (The CAFÉ Investigators, for the Anglo-Scandinavian Cardiac 
Outcomes Trial (ASCOT) Investigators, 2006). 
The therapeutic benefits of antihypertensive drugs are influenced by two major effects: i) the 
effect due to BP reduction; ii) the direct effect of the drug on the vessel wall (Weber et al., 
2005). Drug therapy that favorably influences blood vessel function appears to directly 
enhance the mechanical properties of arterial wall, independent of BP changes. In a 
therapeutic trial on patients with endstage renal failure, a population at very high 
cardiovascular risk, longer survival was strongly related to the drug-induced reversibility of 
aortic stiffness measured by PWV independently of BP evaluation (Guerin et al., 2001).   
Although all classes of antihypertensive drugs reduce BP effectively, they do not exert 
similar benefits on arterial structure and function (Van Bortel et al., 2001). Antihypertensive 
therapy should focus on modulating high PP, the latter parameter contributing to major risk 
of cardiorenal events in older hypertensive subjects (Van Bortel et al., 2001). In these subjects 
who frequently exhibit ISH or a disproportionate increase in SBP over DBP, causing a 
selective widening in PP, the goal of treatment should aim at decreasing SBP with 
maintenance or even enhancing DBP. These targets may be attained by an active 
improvement in arterial stiffness, change in wave reflection and reduction in left ventricular 
ejection (Van Bortel et al., 2001).  
Inhibitors of the renin-angiotensin-aldosterone system (RAAS), calcium channel antagonists, 
nitrosovasodialtors, diuretics and 3-methylglutaryl-coenzyme A inhibitors (statins) appear 
to modulate arterial stiffness (Staessen and Birkenhager, 2005).  
The RAAS inhibitors reduce arterial stiffness by inhibition of the vasoconstrictive action of 
angiotensin II and improvement in endothelial function (Van Bortel et al., 2001). In a 
substudy of the RENAAL clinical trial, administration of Losartan to diabetic patients with 
baseline PP≥90mmHg led to 53.5% risk reduction for ESRD alone and 35.5% risk reduction 
for ESRD or death (Bakris et al., 2003). A similar mode of action has been postulated for the 
aldosterone antagonists (Van Bortel et al., 2001). Calcium channel blockers, by exerting 
direct relaxing effects on vascular smooth muscle cells, appear to also achieve a reduction in 
arterial stiffness and wave reflection. Nitrosovasodialtors effectively reduce central SBP and 
PP, especially in patients with stiff arteries and enhanced wave reflections. The benefits 
provided by nitrates and phosphodiesterase type-5 inhibitors have been attributed to the 
increase in cyclic guanosine monophosphate in vascular smooth muscles (Weber et al., 
2005). Diuretics reduce arterial stiffness by decreasing systemic BP (Cushman et al., 2001 & 
Weber et al., 2005).  
In contrast, in clinical trials, atenolol or pure beta-blockade based-therapy did not provide 
cardiovascular protection compared to that afforded by newer classes of BP lowering agent, 
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despite similar brachial BP levels (Conduit Artery Function Evaluation [CAFÉ] Study – 
Anglo Scandinavian Cardiac Outcomes Trial [ASCOT], 2006).  
Administration of statins to overweight and obese subjects was associated with an 
improvement in arterial stiffness as evidenced by a significant reduction in PWV, 
independent of baseline cardiometabolic risk factors (Orr et al., 2009). 
8. Conclusion 
Increased PP, defined as the difference between inappropriately elevated SBP and reduced 
DBP at any value of MAP has recently emerged as an important and independent predictor 
of enhanced cardiovascular morbidity and mortality, especially in senior subjects. Central 
PP represents a surrogate measure of increased arterial stiffness of the central elastic 
arteries. However, brachial PP is a widely accepted marker of arterial stiffness in older 
subjects due to loss of amplification phenomenon and equalization with central PP. 
In the general population, PP and age are positively correlated after the age of 50 years, 
whereas a negative correlation between these 2 parameters is found in adults younger than 
50 years. 
Interaction between left ventricular outflow and elastic properties of the central arteries 
creates incident forward propagating and reflected backward traveling pulse waves which 
summate either in diastole or systole. In young adults, due to high arterial distensibility, 
both pulse waves summate in diastole boosting central DBP, whereas in older subjects, due 
to increased arterial stiffness, summation occurs in late systole, generating a high SBP and 
loss of peripheral amplification. 
Epidemiologic surveys and clinical studies have demonstrated, in the elderly, a close 
relationship between increased brachial PP and cardiovascular events, stroke, impairment in 
neurocognitive function and dementia, and vascular nephropathy and progression of CKD. 
Therapeutic regimens include lifestyle modifications and pharmacologic medications. 
Therapeutic benefits have been reported when BP reduction has been associated with 
improved arterial function and reduced arterial stiffness. 
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